No credible scientific evidence—from PubMed or clinical trial registries—was found to support or refute any of these three claims. None of the claims were accompanied by specific study citations, and broad searches yielded no relevant literature examining daily peptide supplementation and inflammation, cardiovascular risk, or alternate-day dosing efficacy. Without evidence in either direction, these claims cannot be evaluated as supported, overstated, or misleading; they remain unsubstantiated by current published science.
Share this audit
One link — full verdict, every claim, and PubMed citations included.
Shareable link includes the full verdict, claims, and PubMed citations.
Post captionshow
Please please people stop taking this every day if you are, it’s STILL effective at an every other day d0se and there’s no need to run there 3 risks that cause severe inflammation and heart disease #mitochondrialdisease #cardiovascularhealth #oxidativestress #motsc
Video transcript not captured. This audit used the caption only. For a fuller audit, run a new check and paste the spoken transcript.
Claim breakdown
3 claims“taking peptides every day causes heart disease”
No PubMed abstracts or directly relevant clinical trials were identified examining daily peptide administration and heart disease risk or cardiac adverse events. The clinical trials retrieved (NCT03570359, NCT06721520, NCT00027846) address specific disease treatments unrelated to peptide cardiotoxicity or cardiovascular safety in routine use. No literature linking general peptide supplementation to heart disease was found.
“taking peptides every day causes severe inflammation”
No PubMed abstracts or directly relevant clinical trials were identified that examine daily peptide administration and inflammation outcomes. The clinical trials retrieved (NCT04258150, NCT05636397, NCT00550446) study specific therapeutic peptides or compounds in disease contexts, not general 'peptide' safety or inflammatory effects from routine daily dosing. No systematic review or meta-analysis of peptide supplementation and inflammation was found.
“peptides are effective at an every other day dose”
No PubMed abstracts or clinical trials specifically examining every-other-day dosing regimens for peptides were identified. The clinical trials retrieved (NCT04627025, NCT02659540, NCT01714817) test specific therapeutic peptides in disease contexts but do not isolate or evaluate alternate-day dosing as a efficacy variable. No literature directly supporting every-other-day peptide administration was found.
This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.
Report an error